GR3014907T3 - Muscarinic receptor antagonists. - Google Patents
Muscarinic receptor antagonists.Info
- Publication number
- GR3014907T3 GR3014907T3 GR940404057T GR940404057T GR3014907T3 GR 3014907 T3 GR3014907 T3 GR 3014907T3 GR 940404057 T GR940404057 T GR 940404057T GR 940404057 T GR940404057 T GR 940404057T GR 3014907 T3 GR3014907 T3 GR 3014907T3
- Authority
- GR
- Greece
- Prior art keywords
- alkyl
- pct
- receptor antagonists
- muscarinic receptor
- date jun
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898928042A GB8928042D0 (en) | 1989-12-12 | 1989-12-12 | Muscarinic receptor antagonists |
PCT/EP1990/002043 WO1991009013A1 (en) | 1989-12-12 | 1990-11-28 | Muscarinic receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3014907T3 true GR3014907T3 (en) | 1995-05-31 |
Family
ID=10667813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR940404057T GR3014907T3 (en) | 1989-12-12 | 1995-02-01 | Muscarinic receptor antagonists. |
Country Status (14)
Country | Link |
---|---|
US (1) | US5340831A (el) |
EP (1) | EP0505376B1 (el) |
JP (1) | JPH0678303B2 (el) |
AT (1) | ATE115126T1 (el) |
CA (1) | CA2069910C (el) |
DE (1) | DE69014901T2 (el) |
DK (1) | DK0505376T3 (el) |
ES (1) | ES2064771T3 (el) |
FI (1) | FI95027C (el) |
GB (1) | GB8928042D0 (el) |
GR (1) | GR3014907T3 (el) |
IE (1) | IE64205B1 (el) |
PT (1) | PT96144A (el) |
WO (1) | WO1991009013A1 (el) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6017931A (en) * | 1994-03-01 | 2000-01-25 | Fmc Corporation | Insecticidal compositions containing n-(substituted phenylmethyl)-4-[bis(substituted phenyl)methyl]piperidines |
US5639763A (en) * | 1994-03-01 | 1997-06-17 | Fmc Corporation | Insecticidal N-(substituted arylmethyl)-4-[bis(substituted phenyl)methyl]piperidines |
US5569664A (en) * | 1995-02-16 | 1996-10-29 | Fmc Corporation | Insecticidal n-(substituted arylmethyl)-4-[bis(substituted phenyl) methyl]pi |
EP0948964B1 (en) * | 1996-12-02 | 2003-04-02 | Kyorin Pharmaceutical Co., Ltd. | Novel n-substituted pyrrolidine derivatives and process for preparing the same |
US6693202B1 (en) * | 1999-02-16 | 2004-02-17 | Theravance, Inc. | Muscarinic receptor antagonists |
CN1668585A (zh) | 2002-07-08 | 2005-09-14 | 兰贝克赛实验室有限公司 | 用作蝇蕈碱受体拮抗剂的3,6-二取代氮杂双环[3.1.0]己烷衍生物 |
US7265147B2 (en) | 2002-07-31 | 2007-09-04 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
US7410993B2 (en) | 2002-08-09 | 2008-08-12 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo [3.1.0] hexane deriviatives useful as muscarinic receptor antagonists |
US7288562B2 (en) | 2002-08-23 | 2007-10-30 | Ranbaxy Laboratories Limited | Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists |
TWI295669B (en) * | 2002-10-30 | 2008-04-11 | Theravance Inc | Substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds |
JP2006518707A (ja) | 2002-12-10 | 2006-08-17 | ランバクシー ラボラトリーズ リミテッド | ムスカリン様受容体アンタゴニストとしての3,6−二置換アザビシクロ[3.1.0]ヘキサン誘導体 |
WO2004056767A1 (en) | 2002-12-23 | 2004-07-08 | Ranbaxy Laboratories Limited | 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists |
ATE386738T1 (de) | 2002-12-23 | 2008-03-15 | Ranbaxy Lab Ltd | Flavaxat-derivate als muscarin-rezeptor antagonisten |
US7488748B2 (en) | 2003-01-28 | 2009-02-10 | Ranbaxy Laboratories Limited | 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
WO2004089892A2 (en) | 2003-04-01 | 2004-10-21 | Theravance, Inc. | Diarylmethyl and related compounds having beta2 andrenergic receptor agonist and muscarinic receptor antagonist activity |
AU2003214520A1 (en) | 2003-04-09 | 2004-11-01 | Ranbaxy Laboratories Limited | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
EP1615887A1 (en) | 2003-04-10 | 2006-01-18 | Ranbaxy Laboratories, Ltd. | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
AU2003214535B2 (en) | 2003-04-10 | 2009-09-03 | Ranbaxy Laboratories Limited | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
WO2004089900A1 (en) | 2003-04-11 | 2004-10-21 | Ranbaxy Laboratories Limited | Azabicyclo derivatives as muscarinic receptor antagonists |
TW200510298A (en) | 2003-06-13 | 2005-03-16 | Theravance Inc | Substituted pyrrolidine and related compounds |
WO2005007645A1 (en) * | 2003-07-11 | 2005-01-27 | Theravance, Inc. | Substituted 4-amino-1-benzylpiperidine compounds |
US7250414B2 (en) * | 2004-03-11 | 2007-07-31 | Theravance, Inc. | Diphenylmethyl compounds useful as muscarinic receptor antagonists |
EP1725525A1 (en) * | 2004-03-11 | 2006-11-29 | Theravance, Inc. | Diphenylmethyl compounds useful as muscarinic receptor antagonists |
EP1926709A4 (en) | 2005-08-25 | 2009-06-24 | Rstech Corp | PROCESS FOR THE SYNTHESIS OF A 3-HYDROXYPYRROLIDINE CHIRAL COMPOUND AND DERIVATIVES OF SAID HIGH OPTICAL PURITY COMPOUND |
JP2009512676A (ja) | 2005-10-19 | 2009-03-26 | ランバクシー ラボラトリーズ リミテッド | ムスカリン性受容体アンタゴニストの医薬組成物 |
CA2630478A1 (en) * | 2005-12-27 | 2007-07-05 | Teva Pharmaceutical Industries, Ltd | Processes for preparing darifenacin hydrobromide |
JP5528817B2 (ja) | 2007-02-23 | 2014-06-25 | セラヴァンス, インコーポレーテッド | ムスカリン受容体アンタゴニストとして有用な第四級アンモニウムジフェニルメチル化合物 |
JP2010525058A (ja) | 2007-04-24 | 2010-07-22 | セラヴァンス, インコーポレーテッド | ムスカリン受容体アンタゴニストとして有用な第4級アンモニウム化合物 |
JP5779100B2 (ja) | 2008-11-24 | 2015-09-16 | カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ | 光学的に活性なn−ベンジル−3−ヒドロキシピロリジンの製造方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL76583A (en) * | 1984-10-19 | 1988-08-31 | Robins Co Inc A H | 1-(aminoalkyl)-alpha'alpha-diaryl pyrrolidinyl,piperidino and homopiperidino acetamides and acetonitriles and pharmaceutical compositions containing them |
US4810713A (en) * | 1985-12-20 | 1989-03-07 | A. H. Robins Company, Incorporated | Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl groups used in a method for allergy treatment |
EP0235463A3 (en) * | 1985-12-20 | 1990-01-17 | A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) | N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents |
IN163948B (el) * | 1986-01-17 | 1988-12-10 | Robins Co Inc A H | |
US5233053A (en) * | 1989-03-17 | 1993-08-03 | Pfizer Inc. | Pyrrolidine derivatives |
GB8906166D0 (en) * | 1989-03-17 | 1989-05-04 | Pfizer Ltd | Therapeutic agents |
-
1989
- 1989-12-12 GB GB898928042A patent/GB8928042D0/en active Pending
-
1990
- 1990-11-28 AT AT90917056T patent/ATE115126T1/de not_active IP Right Cessation
- 1990-11-28 JP JP2515786A patent/JPH0678303B2/ja not_active Expired - Fee Related
- 1990-11-28 DK DK90917056.5T patent/DK0505376T3/da active
- 1990-11-28 WO PCT/EP1990/002043 patent/WO1991009013A1/en active IP Right Grant
- 1990-11-28 DE DE69014901T patent/DE69014901T2/de not_active Expired - Fee Related
- 1990-11-28 EP EP90917056A patent/EP0505376B1/en not_active Expired - Lifetime
- 1990-11-28 ES ES90917056T patent/ES2064771T3/es not_active Expired - Lifetime
- 1990-11-28 CA CA002069910A patent/CA2069910C/en not_active Expired - Fee Related
- 1990-11-29 US US07/859,471 patent/US5340831A/en not_active Expired - Lifetime
- 1990-12-10 PT PT96144A patent/PT96144A/pt unknown
- 1990-12-11 IE IE446390A patent/IE64205B1/en not_active IP Right Cessation
-
1992
- 1992-05-22 FI FI922345A patent/FI95027C/fi not_active IP Right Cessation
-
1995
- 1995-02-01 GR GR940404057T patent/GR3014907T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0505376B1 (en) | 1994-12-07 |
EP0505376A1 (en) | 1992-09-30 |
FI922345A (fi) | 1992-05-22 |
IE904463A1 (en) | 1991-06-19 |
IE64205B1 (en) | 1995-07-12 |
ES2064771T3 (es) | 1995-02-01 |
PT96144A (pt) | 1991-09-30 |
US5340831A (en) | 1994-08-23 |
CA2069910C (en) | 1996-11-12 |
JPH0678303B2 (ja) | 1994-10-05 |
ATE115126T1 (de) | 1994-12-15 |
DE69014901T2 (de) | 1995-04-27 |
WO1991009013A1 (en) | 1991-06-27 |
FI95027C (fi) | 1995-12-11 |
FI95027B (fi) | 1995-08-31 |
DE69014901D1 (de) | 1995-01-19 |
JPH04505927A (ja) | 1992-10-15 |
DK0505376T3 (da) | 1995-02-13 |
GB8928042D0 (en) | 1990-02-14 |
CA2069910A1 (en) | 1991-06-13 |
FI922345A0 (fi) | 1992-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8928042D0 (en) | Muscarinic receptor antagonists | |
WO1992005172A3 (en) | Muscarinic receptor antagonists | |
GR3017944T3 (en) | Piperidine and pyrrolidine derivatives. | |
GB9602029D0 (en) | New heterocyclic compounds | |
ATE102183T1 (de) | Muscarin-rezeptor-antagonisten. | |
GR3002140T3 (en) | Muscarinic receptor antagonists | |
GB2183476B (en) | Anthihypertensive combination product | |
GB8928043D0 (en) | Muscarinic receptor antagonists | |
CA2069931A1 (en) | Muscarinic receptor antagonists |